School of Medicine
Showing 1-10 of 13 Results
-
Brent Tan
Clinical Associate Professor, Pathology
Current Research and Scholarly Interests My research interest is in the use of molecular, flow cytometric, and cytogenetic methods to understand and characterize hematopoietic neoplasms. In addition, I have medical oversight of clinical laboratory informatics.
-
Megan Troxell
Professor of Pathology at the Stanford University Medical Center
Current Research and Scholarly Interests Breast pathology, renal pathology with tumors, transplant; immunohistochemistry
-
Albert Tsai, M.D., Ph.D.
Assistant Professor of Pathology at the Stanford University Medical Center
Bio Dr. Tsai received his undergraduate training at the University of California, Los Angeles (B.S., Biochemistry, summa cum laude), followed by combined medical and graduate training at the University of Southern California (M.D., Ph.D., Biochemistry). He completed anatomic and clinical pathology (AP/CP) residency and hematopathology fellowship at Stanford University, receiving board certification in AP/CP and hematopathology. As an instructor, he performed clinical diagnostic duties on the hematopathology service while doing postdoctoral training in the laboratory of Dr. Sean Bendall, with funding from the Damon Runyon Cancer Research Foundation.
As a physician and hematopathologist, he seeks to advance diagnostic hematopathology by mechanistically dissecting human hematopoietic diseases using next generation immunophenotyping. This work combines: 1. practical experience clinically diagnosing human tissue, 2. operational knowledge of mass cytometry/cytometry by time-of-flight (CyTOF) and multiplexed ion beam imaging (MIBI), and 3. fundamental discoveries in the biology of dysplasia/neoplasia. With an understanding of clinical laboratory testing, he aims to bring these techniques into routine clinical diagnostics, potentially to predict susceptibility and monitor response to targeted therapies.
His clinical diagnostic duties are on the hematopathology service, primarily in the diagnosis of lymphomas, leukemias, and other hematopoietic diseases from blood, bone marrow, and tissue samples.
